Results 51 to 60 of about 1,230 (95)

Обзор существующих возможностей и ограничений программы государственных гарантий оказания гражданам бесплатной медицинской помощи

, 2019
Introduction. The state guarantee program for provision of free medical care to citizens is a key regulatory document that describes the actual guarantees of citizens for medical care. The standards of the extent and financing of medical care established
O. I. Ivakhnenko , D. V. Fedyaev , V. A. Lemeshko , В. А. Лемешко, R. V. Gostishchev , Р. В. Гостищев, Д. В. Федяев, О. И. Ивахненко   +7 more
core   +1 more source

Pharmacoeconomic analysis of naftidrofuryl for treatment of ischemic stroke

Качественная клиническая практика, 2018
Strokes are one of the most important causes of death and disability both worldwide and in Russian Federation (RF). This disease requires intensive, prolonged treatment and rehabilitation and thus is associated with considerable temporary disability, as ...
A. E. Cheberda, D. Yu. Belousov, A. N. Bogolepova   +2 more
doaj  

Pharmacoeconomic evaluation of pramipexole extended release monotherapy in early Parkinson’s disease

Качественная клиническая практика, 2018
Objective. Health economic expertise of pramipexole extended release monotherapy at early stages of Parkinson’s disease. Methods. An economic model was developed based on clinical studies to derive comparative information on the effectiveness, utility ...
D. Yu. Belousov, E. V. Afanasyeva
doaj  

Pharmacoeconomic analysis of Actemra^® in first-line treatment of rheumatoid arthritis in the modes of combination and monotherapy

Качественная клиническая практика, 2018
Rheumatoid arthritis (RA) is a severe, autoimmune disorder characterized by relatively high prevalence among working-age adult population, significant quality of life and work performance impact, as well as high risk of complete disability in case of ...
S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov   +2 more
doaj  

Pharmacoeconomical aspects of the treatment of arterial hypertension in patients with type II diabetes mellitus in outpatient department

RUDN Journal of Medicine, 2009
Diabetes mellitus II (DMII) is a chronic disease that has a major social impact. A substantial proportion of the costs of diabetes treatment arises from treating long-term complications, particularly cardiovascular disease (CVD).
J Sh Gushina, E E Loskutova, V K Lepakhin   +2 more
doaj  

Методология проведения анализа «затраты-полезность» при проведении фармакоэкономических исследований

, 2015
pharmacoeconomic cost-utility analysis – CUA is at third place by popularity (10% of studies) among studies of pharmacoeconomic analysis. Main stages of these trials are as follows: cost analysis, utility analysis and results assessment.
И. В. Сороковиков, I. V. Sorokovikov, Р. И. Ягудина, R. I. Yagudina   +3 more
core  

The actual practice of clinical nitrition application in the hospitals of Rostov-on-don city and the region

RUDN Journal of Medicine, 2009
The article is devoted to the problem of actual practice of clinical nutrition in the hospitals of Rostov city and Rostov region. The large reserve in application of clinical nutrition - its use in preoperative period.
I N Bychkov
doaj  

Фармакоэкономика в кардиологии, онкологии и акушерстве [PDF]

, 2016
ЭКОНОМИКА ФАРМАЦЕВТИЧЕСКАЯОНКОЛОГИЯ МЕДИЦИНСКАЯ /ЭКОНОМИКААКУШЕРСТВО /ЭКОНОМИКАФАРМАКОЭКОНОМИКАОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯЛЕКАРСТВ СТОИМОСТЬ ДЛЯ УЧРЕЖДЕНИЙ ИЛИ ОРГАНИЗАЦИЙМЕДИЦИНСКОЙ ПОМОЩИ СТОИМОСТЬКАРДИОЛОГИЯ /ЭКОНОМИКАВ монографии изложены основы ...
Козловский, В. И., Крылов, А. Ю., Пищенко, Ю. А., Лесничая, О. В., Нагибович, С. Ю., Крылов, Е. Ю., Богдан, Е. Л., Крылов, Ю. В., Симанович, А. В., Захаренкова, Т. Н., Легкая, Л. А., Занько, С. Н.   +11 more
core  

Фармакоэкономика бронхиальной астмы в г. Новоуральске [PDF]

, 2009
Цель исследования: оценить эффективность организационных мер по повышению качества оказания помощи больным астмой в г ...
Наумова, В. В., Бельтюков, Е. К., Архипов, М. В.   +2 more
core  

Economic expertise of alirocumab in standard lipid lowering therapy insusceptibility

Качественная клиническая практика, 2018
Usage of PCSK9 inhibitors is a new approach of lipid lowering therapy allowing overcomes as well insusceptibility of standard statins’ therapy as their intolerance.
S. K. Zyryanov, I. N. Dyakov
doaj